Affymetrix Acquires eBioscience
June 26, 2012
Dear Valued Customer,
I am very pleased to announce that on June 25, 2012, eBioscience became part of Affymetrix. The eBioscience solutions encompass one of the world’s largest selections of antibodies, bead-based multiplex immunoassays for flow cytometry, ready-to-use ELISA kits and a broad spectrum of reagents for the analysis of cytokines, growth factors and other soluble proteins for Life Science research and clinical applications. As an industry leader in reagent offerings for multicolor flow cytometry, eBioscience provides a comprehensive and innovative portfolio of antibodies, fluorochromes and reagents for immunology, oncology, cell biology, stem cell biology, and diagnostics.
The breadth of eBioscience solutions is complementary to the Affymetrix portfolio and helps to increase our depth of capabilities to serve our customers in functional biology, translational medicine and clinical validation in basic research through to the clinic and provides product solutions for a wider range of applications from the genome – transcriptome – cellular analyses to clinical signatures.
While we aim to bring new scientific solutions to our customers over time, we also want to preserve what is valued now. As a valued eBioscience customer, you will be glad to know that the same high quality service and support you have come to expect from eBioscience will continue into the future. Manufacturing and support will remain at existing facilities worldwide, and your primary contacts at eBioscience will continue to be your primary contacts now that eBioscience is part of Affymetrix.
For more information or answers to your questions, please visit our web sites at www.affymetrix.com and www.ebioscience.com. Please contact your current sales representative if you have specific questions that the web site may not address.
Frank Witney, Ph.D.